MedPath

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

Not Applicable
Recruiting
Conditions
Parkinson Disease
Registration Number
NCT05933681
Lead Sponsor
Vanderbilt University Medical Center
Brief Summary

The study aims to investigate cognitive impairment associated with Deep Brain Stimulation (DBS) in Parkinson's Disease patients, with a focus on identifying neurophysiology biomarkers of DBS associated cognitive changes. Using neurophysiology data recorded during DBS surgeries and post-implantation, the research intends to identify biomarkers in order to optimize electrode placement, enhance programming, and ultimately minimize DBS-related cognitive side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria

• Scheduled to undergo deep brain stimulation surgery under local anesthesia at Vanderbilt University Medical Center (Arm 1)

  • Active deep brain stimulation system with implantable pulse generator capable of recording local field potentials (Arm 2)
  • Diagnosis of Parkinson's disease as determined by a movement disorders specialist neurologist
  • Age at least 18
  • Able to participate in intraoperative testing
  • English speaking
Exclusion Criteria
  • Age less than 18
  • Not able to participate in intraoperative testing (ex unable to comprehend instructions or follow directions)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Determination of DLPFC beta power a biomarker of DBS associated cognitive impairment in the acute stimulation settingBaseline to end of Deep Brain Stimulation (DBS), approximately 3-4 hours

Working memory tasked will be conducted during surgery, and local field potentials (LFPs) will be recorded from the DLPFC both at rest and during task execution, under two conditions: with and without stimulation.

Determination of STN local field potential biomarkers of DBS mediated cognitive impairment following chronic stimulation1 hour

Local field potentials will be recorded from subthalamic nucleus or globus pallidus internus in patients with an existing DBS system with implantable pulse generator capable of recording local field potentials. Recordings will be performed at rest and during a working memory task, with DBS on and off.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
Isabel Long, BS
Contact
615-421-3046
Isabel.Long@vumc.org
Sarah K Bick, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.